In the first week of his presidency, President Donald Trump signed two executive orders directing the elimination of race- and sex-based preferences across federally funded institutions.
First registrational study to specifically evaluate a targeted treatment for patients living with ocular MG Results support planned Supplemental Biologics License Application (sBLA) submission to U.S.